Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
Patent 4826875 Issued on May 2, 1989. Estimated Expiration Date: 
November 20, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 20, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesRectally absorbable form of L-dopa Patent #: 4663349 InventorAssigneeApplicationNo. 07/123118 filed on 11/20/1987US Classes:514/534, Z or Y radical contains a nitrogen atom514/535The nitrogen of the Z radical is directly bonded to a benzene ring which is directly bonded to the C(=O) groupExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassesA61K 31/195 (20060101)A61K 31/185 (20060101) Foreign Application Priority Data1986-06-10 ITAbstractPharmaceutical compositions for the treatment of Parkinson's disease and neurologic syndromes connected with it, containing as the active principle Levodopa methyl ester optionally combined with other active principles selected from dopaminergi, anticholinergic, antidepressive drugs, carboxylase and monoaminoxidase inhibitors. | |
